283 related articles for article (PubMed ID: 27037978)
1. Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MS.
Mahamuni BS; Jajula A; Awasthi A; Kalariya PD; Talluri MV
J Pharm Biomed Anal; 2016 Jun; 125():219-28. PubMed ID: 27037978
[TBL] [Abstract][Full Text] [Related]
2. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
Kalariya PD; Talluri MV; Patel PN; Srinivas R
J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
[TBL] [Abstract][Full Text] [Related]
4. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
[TBL] [Abstract][Full Text] [Related]
5. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
[TBL] [Abstract][Full Text] [Related]
6. Stability-indicating assay method for acotiamide: Separation, identification and characterization of its hydroxylated and hydrolytic degradation products along with a process-related impurity by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
Thummar M; Patel PN; Samanthula G; Ragampeta S
Rapid Commun Mass Spectrom; 2017 Nov; 31(21):1813-1824. PubMed ID: 28836303
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
8. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
[TBL] [Abstract][Full Text] [Related]
10. Stability-Indicating Reversed-Phase UHPLC Method Development and Characterization of Degradation Products of Almotriptan Maleate by LC-QTOF-MS/MS.
Saibaba B; Vishnuvardhan C; Johnsi Rani P; Satheesh Kumar N
J Chromatogr Sci; 2018 Jan; 56(1):6-17. PubMed ID: 28977362
[TBL] [Abstract][Full Text] [Related]
11. Study on forced degradation behaviour of dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic explanations of hydrolytic, oxidative and photocatalytic rearrangement of degradation products.
Thalluri B; Dhiman V; Tiwari S; Baira SM; Kumar Talluri MVN
J Pharm Biomed Anal; 2020 Feb; 179():112985. PubMed ID: 31780282
[TBL] [Abstract][Full Text] [Related]
12. Selective separation and characterization of the stress degradation products of ondansetron hydrochloride by liquid chromatography with quadrupole time-of-flight mass spectrometry.
Talluri MV; Keshari KK; Kalariya PD; Srinivas R
J Sep Sci; 2015 May; 38(10):1625-32. PubMed ID: 25727389
[TBL] [Abstract][Full Text] [Related]
13. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
[TBL] [Abstract][Full Text] [Related]
14. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
[TBL] [Abstract][Full Text] [Related]
15. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
[TBL] [Abstract][Full Text] [Related]
16. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
[TBL] [Abstract][Full Text] [Related]
17. LC-ESI-MS/MS evaluation of forced degradation behaviour of silodosin: In vitro anti cancer activity evaluation of silodosin and major degradation products.
Vishnuvardhan C; Saibaba B; Allakonda L; Swain D; Gananadhamu S; Srinivas R; Satheeshkumar N
J Pharm Biomed Anal; 2017 Feb; 134():1-10. PubMed ID: 27866053
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS: development and validation of a stability indicating RP-HPLC method.
Ramisetti NR; Kuntamukkala R; Lakshetti S; Sripadi P
J Pharm Biomed Anal; 2014 Jul; 95():256-64. PubMed ID: 24699370
[TBL] [Abstract][Full Text] [Related]
19. Study of degradation behavior of besifloxacin, characterization of its degradation products by LC-ESI-QTOF-MS and their in silico toxicity prediction.
Salunke N; Kharkar PS; Pandita N
Biomed Chromatogr; 2019 Jun; 33(6):e4489. PubMed ID: 30652327
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]